Skip to main content
. 2021 Sep 28;11:745918. doi: 10.3389/fonc.2021.745918

Figure 2.

Figure 2

The association between CpG sites (passing the multiple testing correction) and the breast cancer risk. OR indicates odds ratio; ER, estrogen receptor; MR, mendelian randomization.